These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26846019)

  • 1. [Prognostic significance of fibrosis markers in hepatocellular carcinoma among patients with IFN-based therapy].
    Nakagawa M; Asahina Y
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():668-73. PubMed ID: 26846019
    [No Abstract]   [Full Text] [Related]  

  • 2. [Multicenter study on the inhibition of hepatocarcinogenesis by interferon therapy (IHIT)].
    Yoshida H; Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):463-6. PubMed ID: 15359842
    [No Abstract]   [Full Text] [Related]  

  • 3. Sustained virologic response achieved after curative treatment of hepatitis C virus-related hepatocellular carcinoma as an independent prognostic factor.
    Kanogawa N; Ogasawara S; Chiba T; Saito T; Motoyama T; Suzuki E; Ooka Y; Tawada A; Kanda T; Mikami S; Azemoto R; Kaiho T; Shinozaki M; Ohtsuka M; Miyazaki M; Yokosuka O
    J Gastroenterol Hepatol; 2015 Jul; 30(7):1197-204. PubMed ID: 25682720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C and hepatocellular carcinoma: grist for the mill.
    Sherman M
    Gastroenterology; 2009 Jan; 136(1):39-42. PubMed ID: 19041651
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients].
    Tarao K; Ohkawa S; Tamai S; Shimizu A
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):740-5. PubMed ID: 7563867
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatocellular carcinoma with sarcomatous change arising after eradication of HCV via interferon therapy.
    Idobe-Fujii Y; Ogi N; Hosho K; Koda M; Murawaki Y; Horie Y
    Clin Imaging; 2006; 30(6):416-9. PubMed ID: 17101412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of hepatocellular carcinogenesis by interferon].
    Ikeda K
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():755-63. PubMed ID: 11762051
    [No Abstract]   [Full Text] [Related]  

  • 8. [Interferon treatment for aged patients with hepatitis C].
    Hiramatsu N; Kasahara A; Hayashi N; Imai Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):640-4. PubMed ID: 15359876
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatitis C and alcohol: notes for consensus].
    Jmelnitzky AC
    Acta Gastroenterol Latinoam; 2001 Mar; 31(1):37-8. PubMed ID: 11370179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The natural history of HCV infection: the role of interferon therapy].
    Rumi MG; Romeo R
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):119-22. PubMed ID: 7542482
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluating the efficacy of interferon therapy on hepatitis C patients].
    Shiraha H; Iwasaki Y; Shiratori Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):489-92. PubMed ID: 15359847
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatitis C and alcohol].
    Perlemuter G
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B105-11. PubMed ID: 12180277
    [No Abstract]   [Full Text] [Related]  

  • 13. [Incidence of hepatocellular carcinoma in patients treated with interferon].
    Yokosuka O; Omata M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):805-9. PubMed ID: 7563880
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of IFN therapy on incidence of hepatocellular carcinoma in HCV positive cirrhosis].
    Nishiguchi S; Kubo S; Shiomi S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):600-4. PubMed ID: 15359868
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatitis C virus-related hepatocellular carcinoma].
    Sumi H; Yokosuka O
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():440-5. PubMed ID: 11761989
    [No Abstract]   [Full Text] [Related]  

  • 16. [Risk factors for development of hepatocellular carcinoma in patients with liver cirrhosis associated with hepatitis C virus].
    Matsushita E; Unoura M; Kaneko S; Kobayashi K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):727-30. PubMed ID: 7563864
    [No Abstract]   [Full Text] [Related]  

  • 17. The natural history of hepatitis C virus infection.
    Al-Quaiz MN; Madani TA; Karawi MA
    Saudi Med J; 2003 Jul; 24 Suppl 2():S67-70. PubMed ID: 12897903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma.
    Alkozai EM; Porte RJ; Adelmeijer J; Zanetto A; Simioni P; Senzolo M; Lisman T
    Platelets; 2015; 26(6):577-82. PubMed ID: 25275728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prediction of high risk group of patients with hepatitis-C-virus type liver cirrhosis developing to liver neoplasm].
    Tarao K; Shimizu A; Okawa S; Tamai S
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):1985-91. PubMed ID: 8586918
    [No Abstract]   [Full Text] [Related]  

  • 20. [High risk group for evolution of hepatocellular carcinoma from HCV related liver cirrhosis].
    Hayashi S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):736-9. PubMed ID: 7563866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.